Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | NeoVax |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
Limited information is currently available on NeoVax, a putative peptide personalized tumor vaccine (Apr 2023). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cyclophosphamide + NeoVax | Cyclophosphamide NeoVax | 0 | 1 |
| Ipilimumab + NeoVax | Ipilimumab NeoVax | 0 | 1 |
| Ipilimumab + NeoVax + Nivolumab | Ipilimumab NeoVax Nivolumab | 0 | 2 |
| NeoVax | NeoVax | 0 | 2 |
| NeoVax + Nivolumab | NeoVax Nivolumab | 0 | 2 |
| NeoVax + Nivolumab + Poly ICLC | NeoVax Nivolumab Poly ICLC | 0 | 1 |
| NeoVax + Pembrolizumab | NeoVax Pembrolizumab | 0 | 1 |
| NeoVax + Pembrolizumab + Temozolomide | NeoVax Pembrolizumab Temozolomide | 0 | 1 |
| NeoVax + Poly ICLC | NeoVax Poly ICLC | 0 | 0 |
| NeoVax + Rituximab | NeoVax Rituximab | 0 | 1 |